EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Epigenetic reprogramming in pediatric gliomas: from molecular mechanisms to therapeutic implications

Santiago Haase, Stephen Carney, Maria Luisa Varela, Devarshi Mukherji, Ziwen Zhu, Yingxiang Li, Felipe J Nuñez, Pedro R Lowenstein, Maria G Castro

Trends in Cancer · 2024

DOI: 10.1016/j.trecan.2024.09.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2024. Verfasst von Santiago Haase und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Cell and Developmental Biology, Biomedical…. Hauptthemen laut MEDLINE: Glioma, Epigenesis, Genetic, Brain Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NCI NIH HHS, NIBIB NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brain tumors in children and adults differ greatly in patient outcomes and responses to radiotherapy and chemotherapy. Moreover, the prevalence of recurrent mutations in histones and chromatin regulatory proteins in pediatric and young adult gliomas suggests that the chromatin landscape is rewired to support oncogenic programs. These early somatic mutations dysregulate widespread genomic loci by altering the distribution of histone post-translational modifications (PTMs) and, in consequence, causing changes in chromatin accessibility and in the histone code, leading to gene transcriptional changes. We review how distinct chromatin imbalances in glioma subtypes impact on oncogenic features such as cellular fate, proliferation, immune landscape, and radio resistance. Understanding these mechanisms of epigenetic dysregulation carries substantial implications for advancing targeted epigenetic therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaEpigenesis, GeneticBrain NeoplasmsHumansChildHistonesGene Expression Regulation, NeoplasticMutationChromatinProtein Processing, Post-Translational

Stichwörter der Autor:innen

H3G34RH3K27Mdiffuse hemispheric glioma (DHG)diffuse midline glioma (DMG)pediatric diffuse high-grade gliomas (pHGGs)

Substanzen

HistonesChromatin

Autor:innen und Institutionen

  • Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Cell and Developmental Biology, Biomedical Science Research Building, Ann Arbor, MI 48109, USA; Rogel Cancer Cen…

Förderung

  • NINDS NIH HHS
  • NCI NIH HHS
  • NIBIB NIH HHS
  • University of Michigan Medical Center Rogel Cancer Center
  • National Cancer Institute
  • Leah's Happy Hearts
  • Chadtough Foundation
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Haase, S., Carney, S., Varela, M. L., Mukherji, D., Zhu, Z., Li, Y., Nuñez, F. J., Lowenstein, P. R., & Castro, M. G. (2024). Epigenetic reprogramming in pediatric gliomas: from molecular mechanisms to therapeutic implications. Trends in Cancer. https://doi.org/10.1016/j.trecan.2024.09.007

Vancouver

Haase S, Carney S, Varela ML, Mukherji D, Zhu Z, Li Y, et al. Epigenetic reprogramming in pediatric gliomas: from molecular mechanisms to therapeutic implications. Trends in Cancer. 2024. doi:10.1016/j.trecan.2024.09.007

BibTeX
@article{Haase2024,
  author = {Haase, Santiago and Carney, Stephen and Varela, Maria Luisa and Mukherji, Devarshi and Zhu, Ziwen and Li, Yingxiang and Nuñez, Felipe J and Lowenstein, Pedro R and Castro, Maria G},
  title = {Epigenetic reprogramming in pediatric gliomas: from molecular mechanisms to therapeutic implications},
  journal = {Trends in Cancer},
  year = {2024},
  doi = {10.1016/j.trecan.2024.09.007}
}
Kostenlos starten →